Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Research powered by GOALZEN CAPITAL SERVICES PRIVATE LIMITED · SEBI Research Analyst INH000013448
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
7
Neutral
3
Bullish
4
Bearish
8
Neutral
3
Bullish
35
Bearish
1
Neutral
0
Bullish
31
Bearish
7
Neutral
3
Bullish
4
Bearish
7
Neutral
3
Bullish
4
Bearish
1
Neutral
0
Bullish
31
Bearish
1
Neutral
0
Bullish
31
Bearish
1
Neutral
0
Bullish
31
Investor Presentation
Q1 FY27
Investor Presentation
Q4 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q4 FY25
TANFAC Industries Limited is an Indian fluorochemicals manufacturer focused on hydrofluoric acid, specialty fluorides and downstream fluorochemical products, operating an enlarged HF platform (~29,700 tpa) and recently commissioned solar‑grade DHF capacity while executing a 20,000 tpa HFC‑32 refrigerant project to move up the value chain.
Q1 FY27 revenue was INR187 crores (up 6.3% YoY) with EBITDA of INR28.6 crores and a 15.3% margin; management attributes margin pressure to elevated sulphur, higher power and deferred tax adjustments, but expects cost pass‑through within a 30–45 day pricing cycle.
TANFAC has materially strengthened its balance sheet after a successful INR250 crore QIP and a proposed preferential issue of ~INR100 crores, enabling a net debt‑free position that supports near‑term capex execution for HFC‑32 and follow‑on expansions in solar, AHF and electronic‑grade chemicals.
The company reports strong commercial traction: ~65% of R‑32 capacity pre‑booked under long‑term contracts, solar‑grade DHF largely contracted (80%–85%), and management guidance of ~30% revenue growth for FY27 and >60% for FY28 driven by these commissioned and upcoming projects.
Management emphasises a strategic shift from commodity fluorochemicals to higher‑margin, technology‑driven products including electronic‑grade DHF, HFOs and fluoropolymers, supported by R&D, targeted technology tie‑ups and phased capex planning to broaden end‑market exposure.
Chemicals & Petrochemicals
Commodity Chemicals
7,569 Cr
Low Risk
111.9
37.3
14.5
10.5
3,648.00
1,632.60
Sales CAGR
Profit CAGR
ROE
ROCE
Tanfac Industries Ltd (TANFACIND) is currently trading at 3,500.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
TANFAC Industries Limited is an Indian fluorochemicals manufacturer focused on hydrofluoric acid, specialty fluorides and downstream fluorochemical products, operating an enlarged HF platform (~29,700 tpa) and recently commissioned solar‑grade DHF capacity while executing a 20,000 tpa HFC‑32 refrigerant project to move up the value chain. Q1 FY27 revenue was INR187 crores (up 6.3% YoY) with EBITDA of INR28.6 crores and a 15.3% margin; management attributes margin pressure to elevated sulphur, higher power and deferred tax adjustments, but expects cost pass‑through within a 30–45 day pricing cycle. TANFAC has materially strengthened its balance sheet after a successful INR250 crore QIP and a proposed preferential issue of ~INR100 crores, enabling a net debt‑free position that supports near‑term capex execution for HFC‑32 and follow‑on expansions in solar, AHF and electronic‑grade chemicals. The company reports strong commercial traction: ~65% of R‑32 capacity pre‑booked under long‑term contracts, solar‑grade DHF largely contracted (80%–85%), and management guidance of ~30% revenue growth for FY27 and >60% for FY28 driven by these commissioned and upcoming projects. Management emphasises a strategic shift from commodity fluorochemicals to higher‑margin, technology‑driven products including electronic‑grade DHF, HFOs and fluoropolymers, supported by R&D, targeted technology tie‑ups and phased capex planning to broaden end‑market exposure.
Over the past 52 weeks, Tanfac Industries Ltd has traded between a low of ₹1,632.60 and a high of ₹3,648.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Tanfac Industries Ltd has a market capitalization of approximately 7,569.37. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Tanfac Industries Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 111.91 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 7,569.37 Cr, Tanfac Industries Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Tanfac Industries Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Tanfac Industries Ltd is 111.91. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The company has scheduled the Q1 FY27 earnings conference call for July 27, 2026 at 3:00 PM IST.
The call is scheduled for Monday, 27 July 2026 at 3:00 p.m. IST to discuss Q1 FY 2026-27 results.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
546.80 | 8,035 Cr | 7.81 | 0.88 | 3.84 | 8.86 | 11.25 | 9.06 | ||
3498.90 | 7,569 Cr | 111.91 | 10.48 | 0.07 | 18.80 | 20.80 | 12.82 | ||
575.30 | 4,225 Cr | 63.68 | 0.81 | 3.08 | -0.05 | 1.39 | 0.88 | ||
391.25 | 3,605 Cr | 7.63 | 1.01 | 3.06 | 13.30 | 17.92 | 10.99 | ||
77.67 | 3,522 Cr | 21.98 | 3.26 | 1.29 | 15.16 | 19.94 | 11.09 | ||
208.50 | 3,297 Cr | -8.43 | 0.00 | 0.00 | -7.41 | 0.34 | -6.19 | ||
614.45 | 2,408 Cr | 30.71 | 4.56 | 0.16 | 12.47 | 17.32 | 13.77 | ||
| Median: 7 Co. | — | 546.80 | 3,605 Cr | 21.98 | 1.01 | 1.29 | 12.47 | 17.32 | 10.99 |
